Our response to COVID-19

We're supporting people to maintain their wellbeing and manage isolation.

A special message from NeuRA CEO Professor Peter Schofield AO

I would like to extend my thoughts to you all as we all grapple with the COVID-19 pandemic. I hope that you are taking care of yourselves and those around you in what has and continues to be a difficult time for our community.

As an institute working towards improving health outcomes for all Australians, especially the elderly, we are deeply concerned about the potential impact of COVID-19. The virus takes the heaviest toll on older people, making this health emergency a particular concern for us given so many of our research participants are in this demographic.

Your health is our top priority and while NeuRA’s operations continue remotely, we are taking great care to protect the wellbeing of our staff and especially those who are participating in our studies.

Despite new restrictions on how we all live and work, our researchers are using their ingenuity to continue to advance their studies. For example, researchers are avoiding direct contact with people by working with participants remotely.

Our work on breathing is now especially relevant, with the rapid roll out of breathing training devices for those with spinal cord injury as well as clinical trials that aim to improve breathing and reduce the time a person stays ventilated in the intensive care unit. Both projects have the very real potential to save lives.

We are looking at how we can provide the best advice to the community in these circumstances.  For example, NeuRA’s researchers have put together some helpful information on how we can remain mentally and physically fit while living under government-mandated social distancing measures.

Thank you for your continued support during these challenging and uncertain times. Your generosity keeps NeuRA’s projects going, as we continue to make headway addressing brain and nervous system disorders.

Stay safe and well.

Professor Peter R Schofield AO FAHMS PhD DSc

CEO